News

The Arkansas House and Senate have approved a bill that would force pharmacy benefit managers from holding a pharmacy license ...
CVS Health (CVS) is a top S&P 500 performer in 2025, with year-to-date returns exceeding 50%. Moreover, the stock has shirked ...
Key Takeaways CVS stock surged Tuesday after the company said it expects to meet or exceed its previous outlook for 2025.This ...
The Senate Insurance and Commerce Committee advanced a bill Tuesday (April 8) that would prevent pharmacy benefit managers ...
Tuesday, lawmakers in Arkansas advanced a bill that would essentially eliminate a popular pharmacy chain in the Natural State ...
CVS Health (CVS) closed the latest trading day at $68.87, indicating a -1.87% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily loss of 3.46%.
CVS Health Corp. continues to fight a civil lawsuit that accuses the corporation and its retail pharmacists of wrongfully ...
CVS names Brian Newman CFO and Amy Compton-Phillips CMO as leadership shifts follow Q4 revenue growth and ongoing executive ...
Pharmacy giant Walgreens, a fixture on what’s considered a pivotal corner of Hartford’s Washington Street corridor, confirmed ...
CVS has faced financial challenges, particularly in its Aetna insurance unit, which attracted the attention of investor ...
CVS Health surged 10% intraday and ended yesterday 6% higher. Check out why I think that CVS stock offers a significant ...
Three cases of measles have now been confirmed in Colorado, and health leaders are encouraging vaccination as one of the best ...